Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,427 | -139,805 | -8,908 | 1,983 | -1,657 |
| Depreciation Amortization | 12,308 | 16,490 | 12,986 | 5,068 | 1,797 |
| Income taxes - deferred | -62 | -5,238 | -20,127 | -3,297 | -1,541 |
| Accounts receivable | 15,351 | -10,753 | -10,132 | -1,786 | -290 |
| Accounts payable and accrued liabilities | -8,425 | 414 | 2,018 | -171 | 768 |
| Other Working Capital | 1,467 | -14,905 | -2,258 | -1,097 | -4,472 |
| Other Operating Activity | 33,290 | 145,309 | 21,828 | 5,945 | 6,608 |
| Operating Cash Flow | $-12,498 | $-8,488 | $-4,593 | $6,645 | $1,213 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 56,169 | 8,920 | N/A | N/A | N/A |
| PPE Investments | -6,381 | -10,385 | -8,380 | -1,926 | -675 |
| Net Acquisitions | N/A | N/A | 1,559 | -14,947 | -11,188 |
| Purchase Of Investment | -27,095 | -53,116 | N/A | -1,995 | -2,500 |
| Other Investing Activity | -4,856 | -3,536 | -6,371 | -5,847 | -12,655 |
| Investing Cash Flow | $17,837 | $-58,117 | $-13,192 | $-24,715 | $-27,018 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 0 | 27,306 | N/A | N/A |
| Debt Issued | 0 | 20,000 | 1,550 | 3,159 | N/A |
| Debt Repayment | -498 | -2,164 | -214 | -2,175 | N/A |
| Common Stock Issued | 10,751 | 323 | 1,418 | 101,633 | 1,755 |
| Other Financing Activity | 338 | -1,843 | -32,838 | -539 | -159 |
| Financing Cash Flow | $10,591 | $16,316 | $-2,778 | $102,078 | $1,596 |
| Exchange Rate Effect | 35 | -108 | -23 | N/A | N/A |
| Beginning Cash Position | 19,473 | 69,870 | 90,456 | 6,448 | 30,657 |
| End Cash Position | 35,438 | 19,473 | 69,870 | 90,456 | 6,448 |
| Net Cash Flow | $15,965 | $-50,397 | $-20,586 | $84,008 | $-24,209 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,498 | -8,488 | -4,593 | 6,645 | 1,213 |
| Capital Expenditure | -6,381 | -10,385 | -8,385 | -1,961 | -675 |
| Free Cash Flow | -18,879 | -18,873 | -12,978 | 4,684 | 538 |